September 16, 2014 5:46 PM ET

Biotechnology

Company Overview of Amsterdam Molecular Therapeutics (AMT) Holding N.V.

Executive Profile

Sander van Deventer M.D., Ph.D.

Co-Founder, Advisor, Member of Supervisory Board, Chairman of Remuneration Committee and Chairman of Nominating & Corporate Governance Committee, uniQure N.V.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 8 different industries.

See Board Relationships
60--

Background

Dr. Sander Van Deventer, M.D., Ph.D., is a Managing Partner at Forbion Capital Partners. Dr. van Deventer serves as a Venture Partner at ABN AMRO Capital Benelux since 2004. He is a Co-Founder and interim-Chief Executive Officer at uniQure. He was previously a General Partner at Forbion Capital Partners. He served as a Venture Partner of AAC Capital Partners (ABN AMRO Capital) in 2004. He served as an Interim Chief Executive Officer at Dezima Pharma B.V. Dr. van Deventer ...

Corporate Headquarters

Meibergdreef 61
Amsterdam, Noord-Holland 1105 BA

Netherlands

Phone: 31 20 566 7394
Fax: 31 20 566 9272

Board Members Memberships

Former Vice Chairman
Director
Director
2001-Present
Director

Education

Unknown/Other Education
Vrije Universiteit Amsterdam
Doctorate
University of Amsterdam
PhD
University of Amsterdam
MD
University of Amsterdam

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amsterdam Molecular Therapeutics (AMT) Holding N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.